Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents

NCT01517776 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

28

Enrollment

OTHER

Sponsor class

Stopped due to an altered benefit/risk assessment.

Conditions

Gliomas

Interventions

DRUG: Cilengitide
DRUG: Temozolomide

Sponsor

Martin-Luther-Universität Halle-Wittenberg

Collaborators

[object Object]